The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.

He’ll examine Shingrix's real-world effectiveness in preventing HZ infection while estimating the vaccine’s effectiveness in preventing incident dementia and other adverse cognitive and neurological ...

-- Positive data from 876-patient head-to-head trial versus Shingrix ® shows amezosvatein elicits robust humoral and cellular immune responses with comparatively lower reactogenicity ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit ...

Scientists are developing a cutting-edge vaccine that could stop Clostridioides difficile—a bacteria known for causing severe gut infections—in its tracks. Scientists detailed their ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

Healthcare providers recommend the shingles vaccine Shingrix (recombinant zoster vaccine) for people over 50. It's given in two doses, 2-6 months apart, and is 80-90% effective at preventing shingles.

Some weeks Laja is doing outreach, spending her day educating a community about which vaccines she can provide and what diseases they prevent. “It’s my responsibility to tell the mothers to ...

The company has important products such as Shingrix and Arexvy in its vaccine segment. GSK also presents a strong portfolio of HIV and oncology therapeutics. I also believe that GSK has made some ...

Positive data from 876-patient head-to-head trial versus Shingrix ® shows ... will be presented on poster #597, available October 17 th from 12:15 to 1:30pm PDT in Hall J & K SEATTLE, Oct. 16, 2024 ...

Amezosvatein and Shingrix are adjuvanted recombinant protein subunit vaccines targeting glycoprotein E (gE), the most abundant glycoprotein expressed on the surface of the varicella zoster virus ...